International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-2
Original Article
Necrotizing Fasciitis Leading To Septic Shock – After Preterm Cesarean Section
 ,
 ,
 ,
Published
April 30, 2024
Abstract

Background - Necrotizing fasciitis is a subset of aggressive skin and soft tissue infections (SSTIs) that cause necrosis of the muscle fascia and subcutaneous tissues. The infection typically travels along the fascial plane, which has a poor blood supply. Failure to obtain early diagnosis and delay in initiating appropriate treatment can lead to significant mortality and morbidity.

Case report –  Our patient was a23year old women, G4 A3 with 35 weeks+4 days of gestation with history of recurrent pregnancy loss came with complains of leaking per vagina since 6 hours. Patient was taken up for emergency Caesarean section as NST was non-reactive. On day 4, patient complained of pain at suture site and was febrile, hyperpigmentation was noted surrounding the suture site. Higher antibiotics were started and on day 5 wound was suggestive of necrotising fasciitis, patient was shifted to ICU and managed accordingly. This case report illustrates the challenging diagnosis and management of a case of necrotizing fasciitis.

Discussion - Necrotizing fasciitis following caesarean section is extremely rare with an incidence of 2 in 1000. Necrotizing fasciitis is rapidly spreading and is fatal if left untreated. High index of suspicion and early diagnosis, combined with surgical debridement and broad spectrum antibiotic therapy are required. Clinicians must quickly recognize the distinction between cellulitis manageable with antimicrobial therapy and Necrotizing Fasciitis requiring surgical intervention

Recommended Articles
Loading Image...
Volume-5, Issue-2
Citations
2235 Views
500 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved